Results suggest that patients with lichen planus should be screened for metabolic disorders.

Treatment shows a positive benefit-risk consideration for most patients.

Risultati dell’analisi post hoc di EMPA-REG OUTCOME.

L’uso di questi farmaci nei tumori endocrini è ancora oggetto di dibattito. Una revisione sistematica fa il punto su efficacia, sicurezza e rischio di recidiva

Aldosteronism can be the culprit.

Found in 19% of Chinese patients.

Hypothyroidism, celiac disease, and hyperthyroidism are the most common.

Favorable hormonal effects also seen.

Metformin improved some metabolic parameters and clinical outcomes.

Report elicits great interest from clinicians, endocrinologists and toxicologists.

Visto il diffuso uso del trattamento anche in persone senza ipogonadismo, uno studio ha analizzato il rischio a breve termine di tromboembolia venosa dovuta all'ormone.

The restrictions are being introduced after a safety review found that high-dose cyproterone medicines may increase risk for meningioma.

Bisphenols are known endocrine disruptors.

The link between metabolic syndrome and shift work.